Search results for:

ziprasidone IM

ziprasidone IM
Brand names: Geodon
Form Strength
POWDER FOR INJECTION, INTRAMUSCULAR 20 mg


Medication comments:
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
ziprasidone (Geodon) IM
[n/a]
 20 mg/mL powder Stock @ IDBH? Y
NIOSH Table 2B
Pharmacy:
Receiving / Storage / Preparation


Exposure Risk: low
• Handling/preparation PPE Requirements: n/a
• Receiving from Distributor: Standard
• Pharmacy Storage Area: Carousel
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: n/a
• Omnicell Load: Yes
Transport • Transport (dose is placed inside a plastic sealable bag): Standard
Nursing:
Storage / Administration


Exposure Risk: low
• Handling/administration PPE Requirements: Single pair of CX approved gloves. Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Omnicell
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal / Spills • Disposal of Drug Waste: Full-  blue bin 
Trace/packaging- trash
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: Wear CX gloves;
items used to clean up spill should be placed in a sealed bag and put in  blue bin 
NIOSH Supplemental Information: Developmental toxicity, including possible teratogenic effects at doses similar to human therapeutic doses; an increase in the number of pups borndead and a decrease in postnatal survival at less than MRHD
Reason for exemption of USP<800> Containment Requirements: Purchased in final dosage form for dispensing, product is drawn up by nursing on unit, proper protections in place for administration. Wash off immediately with plenty of water for at least 15 minutes.
*This chemical is not considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200)

Last updated: May. 22, 2025



Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.